Shannon W. McCool

Combined mitigation of the gastrointestinal and hematopoietic acute radiation syndromes by an LPA2 receptor-specific nonlipid agonist.

Duane D. Miller, James I. Fells, Y. Fujiwara, 2015, Chemistry & biology.

Combined Mitigation of the Gastrointestinal and Hematopoietic Acute Radiation Syndromes by an LPA 2 Receptor-Specific Nonlipid Agonist Graphical

Duane D. Miller, James I. Fells, Y. Fujiwara, 2015 .

Lysophosphatidic acid type 2 receptor agonists in targeted drug development offer broad therapeutic potential

L. Johnson, G. Tigyi, A. Balogh, 2019, Journal of Lipid Research.

Mitigation of the Hematopoietic and Gastrointestinal Acute Radiation Syndrome by Octadecenyl Thiophosphate, a Small Molecule Mimic of Lysophosphatidic Acid

Duane D. Miller, L. Johnson, G. Tigyi, 2015, Radiation research.